Results 171 to 180 of about 1,226,813 (207)
Optimal lead time for treatment of infantile epileptic spasms syndrome-a secondary data analysis. [PDF]
Ge W, Pang P, Zhang Z, Wan L, Yang G.
europepmc +1 more source
Identification of topological alterations using microstate dynamics in patients with infantile epileptic spasms syndrome. [PDF]
Ahn SH +5 more
europepmc +1 more source
Distinct T Cell Dysregulation Reflects Disease Severity and Progression in Infantile Epileptic Spasms Syndrome and Lennox-Gastaut Syndrome. [PDF]
Chang L +11 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Infantile epileptic spasms syndrome: When spasms come out of the blue
Epilepsy and BehaviorThis study evaluates the electroclinical features of infantile epileptic spasms syndrome (IESS) suddenly appearing in previously normal patients, aiming to describe clinical outcomes and independent predictors.We retrospectively selected a homogeneous group of patients with IESS from two Italian centers.
Federico Vigevano +2 more
exaly +3 more sources
Seizure: the Journal of the British Epilepsy Association, 2022
Infantile epileptic spasms syndrome (IESS) is the most common type of severe epilepsy in infants. However, etiological frequency and optimized therapy, particularly corticosteroid regimen and dose, remain unknown.An ambispective study of an IESS-diagnosed cohort was conducted.
Xiaohua Liang +2 more
exaly +3 more sources
Infantile epileptic spasms syndrome (IESS) is the most common type of severe epilepsy in infants. However, etiological frequency and optimized therapy, particularly corticosteroid regimen and dose, remain unknown.An ambispective study of an IESS-diagnosed cohort was conducted.
Xiaohua Liang +2 more
exaly +3 more sources
Epilepsia
AbstractObjectiveLead time to treatment (clinical onset of epileptic spasms [ES] to initiation of appropriate treatment) is known to predict outcomes in infantile epileptic spasms syndrome (IESS). Timing the clinical onset of ES is crucial to establish lead time. We investigated how often ES onset could be established to the nearest week.
Heather Olson +2 more
exaly +3 more sources
AbstractObjectiveLead time to treatment (clinical onset of epileptic spasms [ES] to initiation of appropriate treatment) is known to predict outcomes in infantile epileptic spasms syndrome (IESS). Timing the clinical onset of ES is crucial to establish lead time. We investigated how often ES onset could be established to the nearest week.
Heather Olson +2 more
exaly +3 more sources
Pediatric Neurology
Etiology is an important predictor for treatment outcomes of infantile epileptic spasms syndrome (IESS). In Thailand, vigabatrin (VGB) is the first-line treatment for all patients due to the unavailability of adrenocorticotropic hormone. We aimed to determine the etiology of IESS using the 2017 International League Against Epilepsy classification and ...
Kullasate Sakpichaisakul +2 more
exaly +3 more sources
Etiology is an important predictor for treatment outcomes of infantile epileptic spasms syndrome (IESS). In Thailand, vigabatrin (VGB) is the first-line treatment for all patients due to the unavailability of adrenocorticotropic hormone. We aimed to determine the etiology of IESS using the 2017 International League Against Epilepsy classification and ...
Kullasate Sakpichaisakul +2 more
exaly +3 more sources
Response to nitrazepam in infantile epileptic spasms syndrome after failed standard treatment
Epilepsy and BehaviorOver half of children with infantile epileptic spasms syndrome (IESS) do not respond to standard treatments. Nitrazepam has shown efficacy similar to adrenocorticotrophic hormone. This study evaluated response rates, adverse effects of nitrazepam, and factors associated with responders in children with IESS who failed standard treatment.We conducted a ...
Kullasate Sakpichaisakul +1 more
exaly +3 more sources
Infantile epileptic spasm syndrome as a new NR2F1 gene phenotype
International Journal of Developmental Neuroscience, 2023AbstractIntroductionNR2F1 pathogenetic variants are associated with the Bosch–Boonstra–Schaaf optic atrophy syndrome (BBSOAS). Recent studies indicate that BBSOAS patients not only have visual impairments but may also have developmental delays, hypotonia, thin corpus callosum and epileptic seizures.
Yan Liang +5 more
openaire +2 more sources
Infantile Epileptic Encephalopathy with Hypsarrhythmia (Infantile Spasms/West Syndrome) and Immunity
West syndrome is a severe epilepsy, occurring in infancy, that comprises epileptic seizures known as spasms, in clusters, and a unique EEG pattern, hypsarrhythmia, with psychomotor regression. Maturation of the brain is a crucial component.
Terezinha Cresci Braga Montelli +1 more
openaire +2 more sources

